Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
PLSE Pulse Biosciences
- 17.650
- +0.510+2.98%
Close Dec 13 16:00 ET
- 17.650
- 0.0000.00%
Post 20:01 ET
1.09BMarket Cap-21.01P/E (TTM)
17.720High16.790Low314.75KVolume17.290Open17.140Pre Close5.49MTurnover1.83%Turnover RatioLossP/E (Static)61.52MShares22.69052wk High13.72P/B304.09MFloat Cap6.59552wk Low--Dividend TTM17.23MShs Float45.820Historical High--Div YieldTTM5.43%Amplitude1.180Historical Low17.438Avg Price1Lot Size
About Pulse Biosciences Company
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
Company Profile
SymbolPLSE
Company NamePulse Biosciences
Listing DateMay 18, 2016
Issue Price4.00
Founded2014
CEOMr. Kevin P. Danahy
MarketNASDAQ
Employees56
Fiscal Year Ends12-31
Address3957 Point Eden Way
CityHayward
ProvinceCalifornia
CountryUnited States of America
Zip Code94545
Phone1-510-906-4600
Company Executives
- Name
- Position
- Salary
- Darrin R. Uecker
- Co-Principal Executive Officer and Co-Principal Financial Officer, Chief Technology Officer and Director
- 5.39M
- Mitchell E. Levinson
- Chief Strategy Officer
- 1.69M
- Kevin P. Danahy
- Chief Commercial Officer, Co-Principal Executive Officer and Co-Principal Financial Officer
- 5.86M
- Timothy H. Mitsuoka
- Corporate Controller and Principal Accounting Officer
- --
- Robert W. Duggan
- Co-Chairman of the Board
- 257.41K
- Paul A. Laviolette
- Co-Chairman of the Board
- --
- Manmeet Singh Soni
- Lead Independent Director
- 180.07K
- Richard A. van den Broek
- Independent Director
- 208.89K
- Dr. Mahkam Zanganeh
- Independent Director
- 173.00K
- Shelley D. Spray
- Independent Director
- 123.47K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.